Rising Infectious Diseases Fueling Growth In The Anthrax Vaccine Market: Strategic Insights Driving Anthrax Vaccine Market Momentum in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Anthrax Vaccine Market Size By 2025?
In the past years, the anthrax vaccine market has seen consistent growth. We expect expansion from $11.27 billion in 2024 to $11.77 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. The growth witnessed in the historic period can be credited to several factors such as concerns related to biological warfare, demands from the military sector, outbreaks of anthrax, public health readiness measures, and biodefense initiatives.

How Big Is the Anthrax Vaccine Market Size Expected to Grow by 2029?
The market for the anthrax vaccine is predicted to witness consistent expansion in the coming years, reaching up to "$14 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 4.4%. This progression in the prediction period can be linked to global security issues, emerging risks, governmental procurement strategies, and preparation for pandemics. Key trends projected during this period encompass technological progress, improved availability in less developed nations, concentration on developing advanced vaccines, escalated governmental hoarding, and combined research undertakings.

View the full report here:
https://www.thebusinessresearchcompany.com/report/anthrax-vaccine-global-market-report

Which Key Market Drivers Powering Anthrax Vaccine Market Expansion and Growth?
The increasing incidence of infectious diseases is anticipated to boost the expansion of the anthrax vaccine market. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, parasites, or fungi, capable of transmitting directly or indirectly from one person to another. They can cause symptoms that can range from mild to severe, and in some cases, lethal, depending on both the pathogen and the individual's immune response. The surge in infectious diseases can be attributed to changes in world population demographics, urbanization, environmental and land use modifications, along with alterations in human behavior. The anthrax vaccine is widely utilized for anthrax protection, and its role in preventing other infectious diseases is under investigation, through studies into its immunogenicity and adaptability. For example, in February 2023, the Council on Foreign Relations, an American nonprofit entity, reported that 75% of newly discovered or emerging infectious diseases (EIDs) and 60% of known infectious diseases have zoonotic origins. Moreover, globally, zoonoses result in 2.7 million human deaths and 2.5 billion disease episodes in people annually. Consequently, the mounting incidence of diseases is spurring the growth of the anthrax vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15511&type=smp

What Are the Key Trends Driving Anthrax Vaccine Market Growth?
Key players in the anthrax vaccine market are concentrating their efforts on creating novel products and obtaining FDA certification to guarantee safety, effectiveness, and accessibility for those susceptible to anthrax exposure. FDA approval is important as it signifies that the vaccine has undergone extensive clinical trials and is deemed safe for public use, providing a shield against potential negative impacts. For example, in July 2023, Emergent BioSolutions Inc., an American biopharmaceutical firm, gained FDA approval for CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted), formerly referred to as AV7909. The approval was based on data collected from a Phase 2 trial that analyzed Cyfendus's lack of interference with antibacterial drugs, and Phase 3 clinical studies comparing the safety and immune response of the vaccine to BioThrax, the earlier anthrax vaccine. Additionally, creating more effective and safer adjuvants is crucial for addressing issues related to reactogenicity and increasing the overall performance of anthrax vaccines.

What Are the Emerging Segments in the Anthrax Vaccine Market?
The anthrax vaccine market covered in this report is segmented -

1) By Vaccine Type: Cell-Free Protective Antigen (PA) Vaccine, Live Attenuated Vaccine
2) By Application Type: Animal Use, Human Use
3) By Distribution Channel: Hospitals, Pharmacies, Other Distribution Channels

Subsegments:
1) By Cell-Free Protective Antigen (PA) Vaccine: Recombinant Protective Antigen (rPA) Vaccine, Adjuvanted rPA Vaccine
2) By Live Attenuated Vaccine: Live Attenuated Bacillus anthracis Vaccine, Genetically Modified Live Attenuated Vaccine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15511&type=smp

Who Are the Global Leaders in the Anthrax Vaccine Market?
Major companies operating in the anthrax vaccine market are Merck & Co. Inc., GC Biopharma, Emergent BioSolutions Inc., Indian Immunologicals Limited, Valneva SE, PharmAthene Inc., Porton Biopharma Limited, Pfenex Inc., Choong Ang Vaccine Laboratories Co. Ltd., Colorado Serum Company, Inc., Elusys Therapeutics Inc., SIGA Technologies Inc., Inovio Pharmaceuticals, Botswana Vaccine Institute, JOVAC, Prokarium, Soligenix Inc., Vaxart Inc., DynPort Vaccine Company LLC, VECOL S.A

Which are the Top Profitable Regional Markets for the Anthrax Vaccine Industry?
North America was the largest region in the anthrax vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthrax vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15511

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.